author-photo

Marco Gobbi

University of Genoa
University of Bologna

183

Papers

5662

Citations

Citation Trend

Filter By

Papers (129) Sort By

Journal Conference Others

Pre-transplant minimal residual disease assessment and transplant-related factors predict the outcome of acute myeloid leukemia patients undergoing allogeneic stem cell transplantation.

2021 European Journal of Haematology
Show All
- Source
- Cite
- Save
Citations (0)
Inhibitors of A Disintegrin And Metalloproteinases-10 reduce Hodgkin lymphoma cell growth in 3D microenvironments and enhance brentuximab-vedotin effect.

2021 Haematologica
Show All
- Source
- Cite
- Save
Citations (0)
Prognostic relevance of a blastic plasmacytoid dendritic cell neoplasm-like immunophenotype in cytogenetically normal acute myeloid leukemia patients.

2020 Leukemia & Lymphoma
Show All
- Source
- Cite
- Save
Citations (0)
Dexamethasone, oxaliplatin and cytarabine (R-DHAOx) as salvage and stem cells mobilizing therapy in relapsed/refractory diffuse large B cell lymphomas

2019 Leukemia & Lymphoma
Show All
- Source
- Cite
- Save
Citations (3)
The new small tyrosine-kinase inhibitor ARQ531 targets acute myeloid leukemia cells by disrupting multiple tumor-addicted programs

2019 Haematologica
Show All
- Source
- Cite
- Save
Citations (9)
Olaptesed pegol (NOX-A12) with bendamustine and rituximab: a phase IIa study in patients with relapsed/refractory chronic lymphocytic leukemia

2019 Haematologica
Show All
- Source
- Cite
- Save
Citations (24)
Early minimal residual disease assessment after AML induction with fludarabine, cytarabine and idarubicin (FLAI) provides the most useful prognostic information

2019 British Journal of Haematology
Show All
- Source
- Cite
- Save
Citations (9)
Prompt detection of L-asparaginase inactivation is crucial to optimize treatment efficacy also in aggressive lymphomas

2018 Hematological Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Comparison of the Efficacy and Feasibility of R-CODOX-M/IVAC-R Versus Conventional R-CHOP As First Line Regimen for High Risk Diffuse Large B-Cell Lymphoma

2017 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Early Minimal Residual Disease Assessment after Acute Myeloid Leukemia Induction with Fludarabine Cytarabine and Idarubicin (FLAI) Provides the Most Useful Prognostic Information

2017 Blood
Show All
- Source
- Cite
- Save
Citations (0)